Novartis gene therapy poised to expand SMA treatment landscape – Healthcare News
Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully achieved the primary endpoint in...
Gene
Genprex Leadership to Present Gene Therapy Breakthroughs at J.P. Morgan Healthcare Conference
AUSTIN, Texas, Jan. 6, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on...
CRISPR-based Gene Editing Market Report 2024-2030,
Dublin, Oct. 21, 2024 (GLOBE NEWSWIRE) -- The "CRISPR-based Gene Editing Market Size, Share and Trends Analysis Report by Product...
Revolutionizing Healthcare: Gene Therapy Products Market
Gene Therapy Products MarketThe Gene Therapy Products Market sector is undergoing significant transformation, with substantial growth and technological advancements expected...
Thalassaemia gene therapy: NICE approves Nobel Prize-winning CRISPR technology for NHS use
Hundreds of NHS England (NHSE) patients are set to benefit from access to the first gene therapy in Europe for...
Six steps healthcare leaders should consider before launching a cell and gene therapy program
Emerging novel cell and gene therapies allow for the possibility of untethering patients from a lifetime of burdensome, costly chronic...
How will CRISPR gene editing change healthcare?
For years, one medical technology has captivated the scientific community: CRISPR. In 2012, Emmanuelle Charpentier, a microbiologist, geneticist and biochemist,...
World’s first CRISPR-based gene therapy approved for sickle cell anaemia
Casgevy has been approved for treating sickle cell disease and transfusion-dependent beta thalassemia patients aged 12 and older in the...
CRISPR gene editing: Moving closer to home
Around the turn of the century, microbiologists at Danisco USA Inc. had a problem: The bacteria they used to make...
